New Canadian bill proposes to limit access to supplements

For more information go to http://nocodexgenocide.com

C-51 represents is a concerted effort to harmonize Canada to Australian law (where dietary supplements are even more restricted than they are in Canada), and via the FDA's Trilateral Cooperation Charter- the ruling elite intend to roll this train wreck across the line into the USA via the covert initiatives now being conducted with increased speed to deconstruct Canada, US and Mexico in order to force us together into a North American Union Dictatorship.

WHAT C-51 DOES- & WHAT YOU CAN DO ABOUT IT

FROM EITHER SIDE OF THE CANADIAN/US BORDER

You can read C-51 here: http://www2.parl.gc.ca/HousePublications/Publication.aspx?DocId=3398126&

The bill has been dissected by attorney Shawn Buckley in Vancouver who sent me a detailed analysis, some of which I'll provide here. Buckley expects to have a complete constitutional analysis completed by midweek, whereupon he and a core group that I'm in touch with will be approaching all stakeholders in Canada in an effort to mount a huge campaign against it.

The Act gives overly broad discretionary powers to Health Canada inspectors to force compliance on alleged "safety" grounds. Currently, 60% of all licensing applications for Natural Health Products are being rejected by Health Canada. The majority of these are for single ingredient formulations.

Buckley estimates that as multi-ingredient product formulations are considered, fully 70% of license applications will be rejected. If this bill passes into law, it will accelerate the speed with which Health Canada is able to destroy the dietary supplement industry because it will enable inspectors to do far more to tie companies up in totally unecessary red tape. The bill gives Health Canada far more resources to process license applications, which means products will be banned, sooner rather than later.

C-51 gives inspectors broad new powers to force products off the market. The bill moves away from the term "drugs" and introduces the term "therapeutic products".